Velasco, Silvia
Kedaigle, Amanda J.
Simmons, Sean K.
Nash, Allison
Rocha, Marina
Quadrato, Giorgia
Paulsen, Bruna
Nguyen, Lan
Adiconis, Xian
Regev, Aviv
Levin, Joshua Z.
Arlotta, Paola
Article History
Received: 29 October 2018
Accepted: 14 May 2019
First Online: 5 June 2019
Competing interests
: A.R. is an SAB member of Thermo Fisher Scientific and Syros Pharmaceuticals and a co-founder and equity holder of Celsius Therapeutics. The other authors declare no competing interests.